Indeed, the alterations found in these genes such as RYR2, NOTCH1 and DMBT1 have strong association with high tumor burden and tumorigenesis (44–47), possibly resulting in a worse prognosis in lung cancer patients. This evidence concerns the gene RYR2 and neoplasm.